News
Insights from the frontlines of venture
Insights from the frontlines of venture
News and milestones from 25 years in technology and healthcare.
News and milestones from 25 years in technology and healthcare.
JAN 21, 2026
Vi Partners announces first close of its new CHF 150 million fund, reinforcing its long-term commitment to Swiss innovation
Read More
Read more
DEC 05, 2025
iOnctura initiates Phase I/II trial in patients with myelofibrosis ahead of new nonclinical data at ASH
Read More
Read more
DEC 03, 2025
Xeltis secures nearly €50m from the European Investment Bank (EIB) and existing shareholders to advance aXess, its vascular access conduit to the market
Read More
Read more
OCT 27, 2025
Vi Partners celebrates the $3 billion Nexthink valuation, a landmark exit for Swiss Tech
Read More
Read more
OCT 16, 2025
iOnctura debuts cambritaxestat (IOA-289) clinical data in patients with pancreatic cancer at ESMO
Read More
Read more
OCT 15, 2025
Vara earns CE mark as the only AI authorized for an independent second read in mammography, and expands in Europe.
Read More
Read more
OCT 08, 2025
Unlocking Europe’s AI Revolution
Read More
Read more
OCT 06, 2025
Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy
Read More
Read more
OCT 08, 2025
From Founder's Vision To Scalable Success
Read More
Read more
SEP 17, 2025
Vi Partners strengthens its team with three new hires in healthcare investing and operations
Read More
Read more
SEP 04, 2025
Sibylla Biotech Appoints CSO and VP of R&D to Advance PPI-FIT Technology and Pipeline of Folding Interference Small Molecules
Read More
Read more
SEP 10, 2025
JenaValve Announced ESC Guidelines Recognize TAVI as Class IIb Recommendation for Aortic Regurgitation
Read More
Read more
JAN 21, 2026
Vi Partners announces first close of its new CHF 150 million fund, reinforcing its long-term commitment to Swiss innovation
Read More
Read more
DEC 05, 2025
iOnctura initiates Phase I/II trial in patients with myelofibrosis ahead of new nonclinical data at ASH
Read More
Read more
DEC 03, 2025
Xeltis secures nearly €50m from the European Investment Bank (EIB) and existing shareholders to advance aXess, its vascular access conduit to the market
Read More
Read more
OCT 27, 2025
Vi Partners celebrates the $3 billion Nexthink valuation, a landmark exit for Swiss Tech
Read More
Read more
OCT 16, 2025
iOnctura debuts cambritaxestat (IOA-289) clinical data in patients with pancreatic cancer at ESMO
Read More
Read more
OCT 15, 2025
Vara earns CE mark as the only AI authorized for an independent second read in mammography, and expands in Europe.
Read More
Read more
OCT 08, 2025
Unlocking Europe’s AI Revolution
Read More
Read more
OCT 06, 2025
Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy
Read More
Read more
OCT 08, 2025
From Founder's Vision To Scalable Success
Read More
Read more